Improving selection criteria for lung cancer screening: The potential role of emphysema

American Journal of Respiratory and Critical Care Medicine

Volumn 191, Issue 8, 2015, Pages 924-931

  Sanchez Salcedo, Pablo ^a   Wilson, David O ^b   De Torres, Juan P ^a   Weissfeld, Joel L ^b   Berto, Juan ^a   Campo, Arantzazu ^a   Alcaide, Ana B ^a   Pueyo, Jesús ^a   Bastarrika, Gorka ^a   Seijo, Luis M ^c   Pajares, Maria J ^d,e   Pio, Ruben ^d,f   Montuenga, Luis M ^d,e   Zulueta, Javier J ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UAM)   (Spain)

^d UNIVERSITY OF NAVARRA   (Spain)

^e Center for Applied Medical Research ^*  (Spain)

^f UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Emphysema; Low dose computed tomography; Lung cancer screening; National lung screening trial

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; EMPHYSEMA; EUROPE; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; UNITED STATES; AGED; COMORBIDITY; EARLY DIAGNOSIS; INCIDENCE; LUNG NEOPLASMS; MASS SCREENING; MIDDLE AGED; PATIENT SELECTION; PROCEDURES; PULMONARY EMPHYSEMA; RADIOGRAPHY; STATISTICS AND NUMERICAL DATA;

AGED; COMORBIDITY; EARLY DETECTION OF CANCER; EUROPE; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT SELECTION; PULMONARY EMPHYSEMA; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 84927792203     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201410-1848OC     Document Type: Article

References (38)

1. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365: 395-409.
2. Humphrey LL, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, Zakher B, Fu R, Slatore CG. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation. Ann Intern Med 2013;159:411-420.
3. Field JK, Oudkerk M, Pedersen JH, Duffy SW. Prospects for population screening and diagnosis of lung cancer. Lancet 2013;382:732-741.
4. Wood DE, Eapen GA, Ettinger DS, Hou L, Jackman D, Kazerooni E, Klippenstein D, Lackner RP, Leard L, Leung AN, et al. Lung cancer screening. J Natl Compr Canc Netw 2012;10:240-265.
5. American Lung Association. Providing guidance on lung cancer screening to patients and physicians. 2012 Apr 23 [accessed 2013 Oct 17]. Available from: http://www.lung.org/lung-disease/lung-cancer/lung-cancer-screening-guidelines/lung-cancerscreening.pdf
6. Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB. Screening for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143: e78S-92S.
7. Jaklitsch MT, Jacobson FL, Austin JHM, Field JK, Jett JR, Keshavjee S, MacMahon H, Mulshine JL, Munden RF, Salgia R, et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 2012; 144:33-38.
8. Wender R, Fontham ETH, Barrera E Jr, Colditz GA, Church TR, Ettinger DS, Etzioni R, Flowers CR, Gazelle GS, Kelsey DK, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 2013;63:107-117.
9. Tammemägi MC, Katki HA, Hocking WG, Church TR, Caporaso N, Kvale PA, Chaturvedi AK, Silvestri GA, Riley TL, Commins J, et al. Selection criteria for lung-cancer screening. N Engl J Med 2013;368:728-736.
10. Kovalchik SA, Tammemagi M, Berg CD, Caporaso NE, Riley TL, Korch M, Silvestri GA, Chaturvedi AK, Katki HA. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 2013;369:245-254.
11. Pinsky PF, Berg CD. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered? J Med Screen 2012; 19:154-156.
12. Bach PB, Gould MK. When the average applies to no one: personalized decision making about potential benefits of lung cancer screening. Ann Intern Med 2012;157:571-573.
13. de Torres JP, Bastarrika G, Wisnivesky JP, Alcaide AB, Campo A, Seijo LM, Pueyo JC, Villanueva A, Lozano MD, Montes U, et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest 2007;132:1932-1938.
14. Wilson DO, Weissfeld JL, Balkan A, Schragin JG, Fuhrman CR, Fisher SN, Wilson J, Leader JK, Siegfried JM, Shapiro SD, et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 2008;178:738-744.
15. Maldonado F, Bartholmai BJ, Swensen SJ, Midthun DE, Decker PA, Jett JR. Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer? A nested case-control study using quantitative emphysema analysis. Chest 2010;138: 1295-1302.
16. Sanchez PA, de-Torres JP, Wilson DO, Weissfeld J, Campo A, Alcaide AB, Zulueta JJ. Improving NLST criteria for lung cancer screening. Eur Respir J 2014;44(Suppl 58):P352.
17. Bastarrika G, García-Velloso MJ, Lozano MD, Montes U, Torre W, Spiteri N, Campo A, Seijo L, Alcaide AB, Pueyo J, et al. Early lung cancer detection using spiral computed tomography and positron emission tomography. Am J Respir Crit Care Med 2005;171: 1378-1383.
18. International Early Lung Cancer Action Program protocol [accessed 2013 Oct 17]. Available from: http://www.IELCAP.org
19. Bastarrika G, Wisnivesky JP, Pueyo JC, Díaz L, Arraiza M, Villanueva A, Alcaide AB, Campo A, Seijo L, de Torres JP, et al. Low-dose volumetric computed tomography for quantification of emphysema in asymptomatic smokers participating in an early lung cancer detection trial. J Thorac Imaging 2009;24:206-211.
20. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-365.
21. Wilson DO, Weissfeld JL, Fuhrman CR, Fisher SN, Balogh P, Landreneau RJ, Luketich JD, Siegfried JM. The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med 2008;178:956-961.
22. Bach PB, Kattan MW, Thornquist MD, Kris MG, Tate RC, Barnett MJ, Hsieh LJ, Begg CB. Variations in lung cancer risk among smokers. J Natl Cancer Inst 2003;95:470-478.
23. Young RP, Hopkins RJ. Targeted CT image screening and its effect on lung cancer detection rate. Chest 2013;144:1419-1420.
24. Shlomi D, Ben-Avi R, Balmor GR, Onn A, Peled N. Screening for lung cancer: time for large-scale screening by chest computed tomography. Eur Respir J 2014;44:217-238.
25. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS; International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:1763-1771.
26. Infante M, Cavuto S, Lutman FR, Brambilla G, Chiesa G, Ceresoli G, Passera E, Angeli E, Chiarenza M, Aranzulla G, et al.; DANTE Study Group. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med 2009;180:445-453.
27. Lopes Pegna A, Picozzi G, Falaschi F, Carrozzi L, Falchini M, Carozzi FM, Pistelli F, Comin C, Deliperi A, Grazzini M, et al.; ITALUNG Study Research Group. Four-year results of low-dose CT screening and nodule management in the ITALUNG trial. J Thorac Oncol 2013;8: 866-875.
28. Horeweg N, van der Aalst CM, Vliegenthart R, Zhao Y, Xie X, Scholten ET, Mali W, Thunnissen E, Weenink C, Groen HJ, et al. Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial. Eur Respir J 2013;42:1659-1667.
29. Young RP, Hopkins RJ. Lung cancer risk prediction to select smokers for screening CT-letter. Cancer Prev Res (Phila) 2012;5:697-698, author reply 699.
30. Smith BM, Pinto L, Ezer N, Sverzellati N, Muro S, Schwartzman K. Emphysema detected on computed tomography and risk of lung cancer: a systematic review and meta-analysis. Lung Cancer 2012; 77:58-63.
31. Ballaz S, Mulshine JL. The potential contributions of chronic inflammation to lung carcinogenesis. Clin Lung Cancer 2003;5: 46-62.
32. Houghton AM, Mouded M, Shapiro SD. Common origins of lung cancer and COPD. Nat Med 2008;14:1023-1024.
33. Zulueta JJ, Wisnivesky JP, Henschke CI, Yip R, Farooqi AO, McCauley DI, Chen M, Libby DM, Smith JP, Pasmantier MW, et al. Emphysema scores predict death from COPD and lung cancer. Chest 2012;141: 1216-1223.
34. Gould MK. Clinical practice. Lung-cancer screening with low-dose computed tomography. N Engl J Med 2014;371:1813-1820.
35. Ashraf H, Saghir Z, Dirksen A, Pedersen JH, Thomsen LH, Døssing M, Tønnesen P. Smoking habits in the randomised Danish Lung Cancer Screening Trial with low-dose CT: final results after a 5-year screening programme. Thorax 2014;69:574-579.
36. Gomez MM, Lo Biondo-Wood G. Lung cancer screening with low-dose CT: its effect on smoking behavior. J Adv Pract Oncol 2013;4: 405-414.
37. Luengo-Fernandez R, Leal J, Gray A, Sullivan R. Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol 2013;14:1165-1174.
38. van Iersel CA, de Koning HJ, Draisma G, Mali WPTM, Scholten ET, Nackaerts K, Prokop M, Habbema JDF, Oudkerk M, van Klaveren RJ. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007;120:868-874.